Whole-body diffusion-weighted imaging in lymphoma

C. Lin, E. Itti, A. Luciani, C. Haioun, M. Meignan, A. Rahmouni*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

The current evidence regarding the usefulness of whole-body diffusion-weighted magnetic resonance imaging (DWI) in lymphoma is reviewed. DWI is capable of combining anatomical and functional information and is becoming a valuable tool in oncology, in particular for staging purposes. DWI may prove to be a useful biomarker in clinical decision making for patients with lymphoma. Large-scaled prospective studies are needed to confirm these preliminary results.

Original languageEnglish
Pages (from-to)S172-S178
JournalCancer Imaging
Volume10
Issue numberSPEC. ISS. A
DOIs
StatePublished - 2010
Externally publishedYes

Keywords

  • FDG-PET/CT
  • Lymphoma
  • Response assessment
  • Staging
  • Whole-body DWI

Fingerprint

Dive into the research topics of 'Whole-body diffusion-weighted imaging in lymphoma'. Together they form a unique fingerprint.

Cite this